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SD      - STANDARD DEVIATION 
 
CAD   - CORONARY ARTERY DISEASE 
 
SLE   - SYSTEMIC LUPUS ERYTHEMATOSIS 
 
HE     - HEMATOXYLLINE AND EOSINE 
 
PAS   - PERIODIC ACID SCHIFF 
 
GBM   -GLOMERULAR BASEMENT MEMBRANE 
 
MCD   -MINIMAL CHANGE DISEASE 
 
FSGS   -FOCAL SEGMENTAL GLOMERULOSCLEROSIS 
 
MN   -MEMBRANOUS NEPHROPATHY 
 
MPGN- MEMBRANO PROLIFERATIVE GLOMERULONEPHRITIS 
 
PIGN -POST INFECTIOUS GLOMERULONEPHRITIS 
 
LN -LUPUS NEPHRITIS 
 
LM- LIGHT MICROSCOPE 
 
EM- ELECTRON MICROSCOPE 
 
HIV - HUMAN IMMUNODEFICIENCY VIRUS 
 
NSAID- NON STEROIDAL ANTI INFLAMMATORY DRUGS
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INTRODUCTION 
The kidney is the mysterious organ that has a major role in excreting 
waste products, regulating body fluids and balancing soluble ions in the 
body(1).The object of this study is to assess clinical and histopathological profile 
ofkidney disease in patients who underwent renal biopsy and differential 
diagnosis of the common renal disease and interpretation of these results. 
The beginning of systematic study of Proteinuria and haematuria can be 
dated back to Sir Richard Bright who is referred to as the Father of 
Nephrology(2). The persistentlyincreased 24 hr. protein excretion (150mg/day) 
OR the urine protein/creatinine ratio in a random urine sample of greater than 
0.2g is usually a marker of  the kidney damage. Increased excretion of albumin 
(>30mg/day) is a sensitive marker ofchronic kidney disease due to diabetes, 
glomerular disease and hypertension.Also increased excretion of low molecular 
weight globulins is a sensitive marker for few types of tubulo-interstitial 
diseases. 
Haematuria can be microscopic or macroscopic and it can occur in 
various glomerular and tubulointerstitial diseases of the kidney. Though 
haematuria occurs mostly in nephritic syndrome, sometimes it may also occur in 
nephrotic syndrome. Renal biopsy canbe done in patients with some 
systemicdisorders where knowing the nature of renalinvolvement has a great 
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therapeutic andprognostic implication. It can also be done inthe patients who 
fail to improve inspite of optimumtherapy.So correlating Proteinuria, 
haematuria, oliguria, oedema and other comorbid conditions with the pathology 
found onrenal biopsy will help us in a better understanding ofthe kidney 
diseases. Thus one can take preventive as well asearly therapeutic measures to 
delay the consequencesof the kidney diseases. 
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AIM OF THE STUDY 
To study the clinical and histopathological profile of the patients who 
underwent renal biopsies. 
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OVERVIEW 
1. Nephrons  
The functional and the basic unit of the kidney is the nephrons(3) which are 
composed of renalcorpuscle (glomerulus and Bowman's capsule), and the 
cylindrical epithelial-lined tubularcomponent (proximal tubule, Henle`s loop 
andthe distal tubule). 
2.Kidney histology 
2.1 Glomerulus 
Glomerulus was first described by Malpighi(4) and then it was clearly explained 
by bowman(5,6). It contains glomerular tuft and bowman’s capsule which is the 
dilated part of proximal tubule(7). Glomerulus is lined internally by endothelium 
and it is supported by mesangium, the matrix and number of cells. 
 
 
Electron micrographic appearance of the juxtaglomerular apparatus 
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2.2 Proximal tubule 
It contains two parts. One is convoluted part and another one is straight 
part(8). The convoluted part is situated in cortex and the straight part is situated 
in medulla. Its total length is 11micrometer. It’s lined by columnar or cuboidal 
cells. The major function of proximal tubule is reabsorption of almost more than 
60% of glomerular ultra-filtrate. 
 
Electron micrographic appearance of the proximal tubule 
2.3 Henle`s loop 
              Henle’s loop is situated between the proximal tubule and the distal 
tubule. It is a U shaped loop. It is lined by flat type cells without brush border. 
They transport the water, sodium and chloride passively. 
13 
 
 
Thick ascending limb of loop of henle 
 
2.4 Distal tubule 
Distal tubule is lined by cuboidal cells with eosinophil rich cytoplasm. It 
involved in active transport of sodium chloride, which is the main function of 
distal tubule(9). It is connected distally to collecting ducts. 
 
Pars convoluta segment of the distal tubule. 
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2.5 Collecting duct 
Collecting duct has three parts, 1) outer medullary part, 2) inner 
medullary part, 3) cortical part(10). First two parts are lined by different epithelial 
cells. Cortical part is lined by cuboidal cells without brush border. Two types of 
cells are present in collecting ducts the principal cells and the intercalated cells. 
P cells secrete the potassium into the cortical collecting duct. I cells have many 
enzymes like carbonic anhydrase II(11). 
 
Principal cell from cortical collecting duct 
 
5. Renal biopsy 
First renal biopsy was done in United States a hundred years before (12). 
But its clinical use became more after 1950s (13, 14). It is useful to localise the 
lesion, to quantify and qualify the lesion, to know the extent of the lesion and 
also to know the response to the treatment and to follow up the patient.  
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7. Biopsy technique 
It can be done either by Nephrologist or Radiologist. In olden days it was 
done by true cut method. But nowadays it is done by biopsy gun (15). It is done in 
prone position for native kidney and in supine position for transplanted kidney. 
It is done under local anaesthesia with ultrasound guidance by using 16 or 14 
gauge needle(16).But for biopsy of renal mass 18-21 gauge needles are 
betterchoices(17,18,19). The appropriate place of taking biopsy is juxtamedullary, 
because glomeruli will involve earlier in focal segmental glomerulosclerosis.  
 
 
 
Biopsy technique 
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8. Risks 
Renal biopsy is a painful procedure. The most common complication is 
microscopic haematuria(20,21). Other complications (22,23,24,25) are macroscopic 
haematuria, perinephric hematoma, arteriovenous fistula, renal pelvic damage, 
injury of adjacent organs, need of blood transfusion, renal tissue loss and rarely 
death. These complications can be minimised by ultrasonogram guidance. 
 
9. Gross inspection  
After taking biopsy, the biopsy material should be placed in a drop of 
normal saline and it should be examined under microscope for colour and 
appearance. While handling the specimen one should not use forceps, because it 
will cause artefacts(26,27,28). Red coloured hemispherical tissues are glomeruli. 
The biopsy material should be divided fixed in a proper solution without any 
delay, to prevent drying of the specimen. The various stains used for staining 
are HE stainsMethenamin silver, Masson Trichrome, periodic acid Schiff, 
Congo red and Reticulin. 
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10. Fixatives 
Neutral buffered formaldehyde is suitable for light microscope, 
immunohistochemistry and molecular studies. Mercury based fixatives like 
Zenker’s, Karnowsky’s and Bouin’s fluid are appropriate for light microscope. 
But they are not preferred fixatives for immunohistochemistry and molecular 
studies. A modified Carnoy fixative is used for both light microscope and 
electron microscope and it is called as Methacaren(27,28). Microwave devices are 
used for processing and fixing, whenever immediate results are required. 2-3 % 
glutaraldehyde is usually used for electron microscope. Immunofluorescence 
samples should not be fixed. They should be sent in Michel’s media. 
 
11. Sectioning and staining  
After the histological processing and paraffin embedding, the tissues are 
sectioned by the microtome. Then these sections are prepared as thin as 3 μm or 
less for the light microscopy. Thicker sections are needed forCongo red and for 
immunohistochemistry staining.The most useful stains for the light microscopy 
are Haematoxylin and Eosin (H&E), Periodic Acid Schiff (PAS), Trichrome, 
Congo red, Methanamine silver and Reticulin.H&E highlights mainly the cells 
well, while Methenaminesilver reveals mainly the basement membrane and 
thematrix of connective tissues. In PAS staining, there will be good highlighting 
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of cells andthe basement membrane. Trichrome staining is suitable for the 
basement membrane, fibrosis and for the assessment of deposits. Congo  
red is used for amyloid discovering while elastin stainslikeReticulin are helpful 
for identifying vascular lesions 
 
HE staining 
 
 
Silver staining 
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12. Specimen adequacy 
There is always a question of how much tissue is necessary for the 
diagnosis of renal disease. In the diffuseglomerular diseases, such as  
Amyloidosis and the membranous glomerulopathy, oneglomerulus is enough 
for the diagnosis. In the diagnosis of focal diseases, considering the random 
distributionof the abnormalities, the probability of finding any glomerulopathy 
is represented by thebiennialequation (29,30,31). For example, if we have 10 
glomeruli and disease exist in 10% and 35% ofthem, we will be having 65% 
and 95% positive report in the biopsy respectively. 
Fogo mentioned 25 and 10 glomeruli are needed for the most accurate 
diagnosis in lightmicroscopy for the native and the transplanted kidneys 
respectively. In a study it was notedthat a specimen with at least 25 glomeruli 
are needed for the diagnosis of chronic lesions of thekidney (32,33).There is some 
semi-quantification of pathologic findings including glomeruli number, 
mesangial matrix volume, inflammatory cell infiltrate, percentage offibrosis, 
percentage of affected glomeruli and atrophy in different patients. Also some 
quantification techniques in renal biopsy have been reported (32,33,34,35). These 
quantifications techniques are helpful in monitoring the patientsand their 
response to the therapy as well as comparison of the different biopsies samples 
and theircorrelation with the clinical points.The quantification methods require 
a standard protocol for the processing and the sectioning. 
20 
 
13. Differential diagnosis of various renal lesions 
Renal biopsies are not only useful in diagnosis and differentiating various 
diagnosis but also useful in knowing the severity and extent of the disease and 
to quantify the irreversible scarring. There are four main parts in the kidney 
which include glomeruli, interstitium, tubules and vascular part. Primary 
changes will occur in any of these structures and secondary changes will occurs 
in other structures. So meticulous and stepwise approach is needed to identify 
the primary and secondary changes. Glomerular changes are inflammation, 
basement membrane changes, scarring, spikes, fibrinoid exudates,deposits and 
hypercellularity.Tubular changes are cellular injuries, atrophy, regeneration, 
cast, edema,fibrosis and crystals.Interstitium pathologiesinclude cellular 
infiltrate, edema, and fibrosis(36,37,38). Vascular partchanges are inflammation, 
sclerosis, thrombosis and hyalinosis. 
14. Glomerular lesions 
There is a standard terminology for the glomerular involving lesions report of 
which is stated by Jennette and et al(39,40,41). 
• Focal- less than 50% of glomeruli involvement 
• Diffuse-more than 50% of glomeruli involvement 
• Segmental- part of a glomerulus involvement 
• Global- all of the glomerulus are involved 
• Mesangial hypercellularity-four or more nuclei in the mesangial region 
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• Endocapillary hypercellularity: means increased cellularity internal to 
the GBM composed byleukocytes, endothelial cells or mesangial cells. 
• Extracapillary hypercellularity: means increased cellularity in 
Bowman`s space (more than the onelayer of the parietal or the visceral 
epithelial cells or monocyte/macrophage). 
• Crescent: means extracapillary hypercellularity other than the epithelial 
hyperplasia of the collapsingvariants of FSGS. 
• Fibrinoid necrosis: means lytic destruction of cells and matrix with 
deposition of the acidophilicfibrin-rich material. 
• Sclerosis: means increased collagenous extracellular matrix that is 
expanding to the mesangium,obliterating capillary lumens or forming 
adhesions to the Bowman`s capsule 
• Hyaline: means glassy acidophilic extracellular material. 
• Membranoprolifrative: means combined capillary wall thickening and 
the mesangial or endocapillaryhypercellularity. 
• Lobular (hypersegmented): means expansion of segments that are 
demarcated by interveningurinary space. 
• Mesangiolysis(42,43,44,45,46,47)-detachment of paramesangial GBM from the 
mesangial matrix or lysis of themesangial matrix.  
• Focal glomerulonephritis- includes inflammatory lesions in less than 
50% of the glomeruli.  
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Thedifferential diagnoses are categorised based on the age and are as 
follows 
<15 years 
1. IgA nephropathy Immunofluorescence micrograph of IgA nephropathy 
15-40 years 
1. thin basement membrane disease 
2. IgA nephropathy 
3. systemic lupus erythematous 
 
49 years female with diffuse proliferative lupus nephritis -IV 
4. mesangial proliferative glomerulonephritis 
5. hereditary nephritis 
>40 years 
1. IgA nephropathy 
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Diffuse glomerulonephritis -will affect most or all of the glomeruli and the 
differential diagnosesbased on the age are: 
<15 years 
1. membranoproliferative glomerulonephritis 
2. post infectious glomerulonephritis 
15-40 years 
1. Post infectious glomerulonephritis 
2. Systemic lupus erythematous 
>40 years 
1. Post infectious glomerulonephritis 
2. Rapid progressive glomerulonephritis 
3. vasculitis 
4. Fibrillary glomerulonephritis 
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Nephrotic syndrome 
Associated with proteinuria,lipiduria and hypertension 
Differential diagnosesaccording to the age include 
<15 years 
1. Minimal change disease 
2. Mesangioproliferative glomerulonephritis 
 
35year female with hypothyroidism, hypertension and hematuria  
 
3. Focal segmental glomerulosclerosis 
 
40 year old male diabetic with proteinuria-FSGS 
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15-40 years 
1. Diabetic nephropathy 
2. Preeclampsia 
3. Post infectious glomerulonephritis 
4. Focal segmental glomerulosclerosis 
5. Minimal change disease 
 
26 year female with anasarca-MCD 
 
6. Membranous nephropathy 
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>40 years 
1. IgA nephropathy 
2. Focal segmental glomerulosclerosis 
3. Amyloidosis 
4. Post infectious glomerulonephritis 
5. Membranous nephropathy 
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The glomerulus lesions are categorized - 
Sclerosis 
1. Collapsing 
2. Usual 
3. Secondary  
4. Tip lesion of FSGS 
Crescent 
According to cellular and degree of fibrous: 
1. Cellular 
2. Fibrous 
3. Fibrocellular 
According to immune deposits 
1. Pauci immune 
 
40 years old female presented with hematuria-pauci immune crescentic glomerulonephritis 
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Proliferation 
 
Mesangial with nodules 
1. Membranoprolifrative glomerulonephritis 
2. Chronic infection related glomerulonephritis 
3. IgA nephropathy 
 
Mesangial without deposits 
1. Focal segmental glomerulosclerosis 
2. Minimal change disease 
3. Early diabetic nephropathy 
 
Mesangial and endocapillary 
1. Proliferative lupus nephritis 
2. Membranoprolifrative glomerulonephritis 
3. Dense deposit disease 
4. Cryoglobulinemia glomerulonephritis 
5. immunotactoid glomerulopathy 
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6. Postinfectious glomerulonephritis 
 
 
35 years female - LM of  PSGN showing influx of neutrophils 
 
 
 
IF microscopy of the same patient showing C3 deposits  
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7. fibrillary glomerulonephritis 
 
LM picture of fibrillary glomerulonephritis 
 
Unusual lesions 
1. Foamy macrophages intraglomerular: 
2. Foamy podocytes 
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It might be remembered that each specific histological pattern in the light 
microscopy could beseen in different diseases 
No abnormality 
1. minimal change disease 
2. Thin basement membrane nephropathy 
 
Thick capillary walls only 
1. Thrombotic microangiopathy 
2. Membranous glomerulopathy 
 
Thickened walls with mesangial expansion without the hypercellularity 
1. Diabetic glomerulopathy 
2. Membranous glomerulopathy with mesangial deposits 
3. Amyloidosis 
4. Fibrillary glomerulonephritis 
5. Dense deposit disease 
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6. Monoclonal Ig deposition disease 
 
 
LM picture of  47 year male with cast nephropathy due to multiple myeloma  
 
 
IF picture of same patient showing lambda chain deposits 
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Focal segmental glomerulosclerosis 
1. Healing of previous glomerular injuries 
2. Minimal change disease 
3. Hypertension 
4. Hereditary nephritis 
5. Chronic phase of the focal glomerulonephritis 
 
Membranous injury 
1. Underlying malignancy 
2. Drug consumption such as gold, penicillamine, mercury 
3. Chronic hepatitis B 
4. Systemic lupus erythematous 
 
Membranoprolifrative glomerulopathy 
1. Membranoprolifrative glomerulonephritis 
2. Diabetic glomerulonephritis 
3. Systemic immune complex disease 
4. HepatitisC 
5. Systemic lupus erythematous 
6. Infectious endocarditis 
7. Fibrillary glomerulonephritis 
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8. Thrombotic microangiopathy 
 
23years female with post LSCS AKI – fragmented RBC and thrombi  
 
9. Immunotactoid glomerulopathy 
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According to serologic studies 
1. Anti GBM antibody: anti GBM antibody disease 
 
 
LM picture of Anti GBM Antibody disease – shrinkage of glomerular tuft 
 
2. Ant streptococcal antibody-post streptococcal glomerulonephritis 
 
LM picture of PIGN 
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According to the decreased serum complement level 
1. Mixed cryoglobulinemia 
2. Postinfectious glomerulonephritis 
3. Lupus nephritis 
4. Membranoprolifrative glomerulonephritis 
According to the presence of acute renal failure 
1. Minimal change disease with acute interstitial nephritis of NSAIDs 
2. Idiopathic minimal change disease 
3. Collapsing focal segmental glomerulosclerosis 
4. crescentic glomerulonephritis 
 
 
-  
 
 
 
 
 
LM picture of crescentic glomerulonephritis 
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15. TUBULAR LESIONS 
I. Acute tubular cell injury 
1. Acute tubular necrosis  
2. Hyaline droplet formation  
3. Vacuolar change (fine and the diffuse appearance) 
a. Fatty change  
b. Foam cells 
c. Hypokalemic nephropathy  
d. Hydropic change  
II. Tubular casts  
Areprincipal histological feature of the light chain disease, 
myoglobinuria,hemoglobinuria, oxalate nephropathy, urate nephropathy, 
nephrocalcinosis and the druginduced tubular lesions. 
• Hyaline: seen in renal failure or low urine output states 
• WBC: seen in tubulointerstitial inflammation 
• Epithelial cell or granular: seen in acute tubular injury 
• RBC: seen in glomerular bleeding 
• Large hyaline fractured: seen in light chain casts (often accompanied by 
the giant cells andthe neutrophils) 
• Coarse granular acidophilic or red brick: indicates myoglobulin or 
hemoglobin 
38 
 
III. Tubular atrophy 
IV. Tubulitis  
V. Tubular basement membrane changes  
 
16.INTERSTITIUM LESIONS 
The lesions of the interstitium that can be observed in the light 
microscopy are listed here (5 types withmodification). 
• No pathologic changes 
• Expansion and edema (due to the increased permeability of the vessels) 
• Expansion with the leukocyte infiltration 
• Foam cells 
• Expansion with the neoplastic cells 
• Crystals 
• Fibrosis 
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17. VASCULAR LESIONS 
The main injuries of the vascular elements are listed here (5 types with 
modification). 
1. Vasculitis 
2. Emboli 
3. Deposition of the materials 
4. Hypertension induced injuries 
 
40 years male with hypertension – fibrinoid necrosis 
 
 
 
 
 
 
 
 
 
40 
 
 
 
 
 
 
 
 
 
 
METHODS  
AND 
 MATERIALS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 
    METHODS AND MATERIALS 
 
 
This study is done on patients who underwent renal biopsy at the 
Department of Medicineand Nephrology,Government Royapettah hospital 
(GRH), Chennai. Numberof patients studied was 50. They were in the agegroup 
14-60 yrs. Out of 50 patients, 21 were female and 29 were male.The patients 
selected were presented with either nephrotic or nephritic features, with 
hematuria of either microscopic or macroscopic, Proteinuria of Nephrotic or 
nephritic range and renal failure. Biopsy done in post-transplant patients is 
excluded from the study. 
 
Study group: patients underwent renal biopsy in government Royapettah                                                   
hospital during the period from 2011 to 2014. 
 
Study design:cross sectional study. 
 
Study period: April-2015 to sep-2015 
 
Place of the study: Government Royapettah hospital. 
Conflict of interest:nil. 
Hazards of the study:nil. 
Sample size: 50  
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METHODOLOGY 
After obtaining proper permission from Superintendent of the 
Government Royapettah hospital, details of the patients who underwent renal 
biopsy during the year from 2011 to 2014 were collected from medical records 
department in Government Royapettah hospital, which includes detailed 
presenting complaints, past history of hypertension, diabetes, dyslipidemia 
coronary artery disease, hypothyroidism, systemic lupus erythematous, 
Amyloidosis, renal diseases, NSAID, use of native treatment, detailed personal 
history of diet pattern, alcohol abuse, smoking, illicit drug abuse, HIV, 
HEPATITIS viral markers status, examination findings like pallor, anasarca, 
skin lesions, blood pressure, laboratory investigations like urine routine, 
complete hemogram, random blood sugar, blood urea, serum creatinine, serum 
electrolytes, lipid profile, viral markers study for retrovirus and hepatitis 
viruses, ultrasonogram abdomen and special investigations like anti-nuclear 
antibodies in some occasions. 
INCLUSION CRITERIA 
Renal biopsy inPatients presented with nephrotic or nephritic features with 
microscopic or macroscopic hematuria and renal failure. 
EXCLUSION CRITERIA  
Renal biopsy in post-transplant patients 
 
43 
 
DATA COLLECTION 
The data of the each patient was collected on a proforma specially 
designed for this study and the proforma contains demographic details of the 
patient, clinical details including history and examination particulars, laboratory 
investigation results and histopathological report of each patient. 
 
STATISTICAL ANALYSIS 
All  the  observations  in  this  study  analysed  statistically  using  SPSS  
20.0  software  and  CHI  SQUARE  test  is  used . P  value of <0.05 is taken as 
significant. 
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OBSERVATION AND RESULTS 
 
AGE IN YEARS 
 
AGE IN 
YEARS FREQUENCY PERCENT 
Below 20 8 16.0 
21-30 12 24.0 
31-40 14 28.0 
41-50 9 18.0 
51-60 6 12.0 
Above 60 1 2.0 
 
 
 
 
 
 
 
 
16%
24%
28%
18%
12%
2%
AGE DISTRIBUTION
Below 20 21-30 31-40 41-50 51-60 Above 60
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SEX 
 
SEX FREQUENCY PERCENT 
Male 29 58.0 
Female 21 42.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58%
42%
GENDER
Male Female
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SMOKING 
 
SMOKING FREQUENCY PERCENT 
Yes 16 32.0 
No 34 68.0 
 
 
 
 
 
 
 
 
 
 
 
32%
68%
SMOKING
Yes No
48 
 
 
 
 
ALCOHOL 
 
 
ALCOHOL FREQUENCY PERCENT 
Yes 14 28.0 
 
No 36 72.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
28%
72%
ALCOHOL CONSUMPTION
Yes No
49 
 
 
 
 
EDEMA 
 
EDEMA FREQUENCY PERCENT 
Yes 22 44.0 
 
No 28 56.0 
 
  
 
OLIGURIA 
 
OLIGURIA FREQUENCY PERCENT 
Yes 14 28.0 
 
No 36 72.0 
 
 
  
HAEMATURIA 
 
HEMATURIA FREQUENCY PERCENT 
Yes 10 20.0 
 
No 40 80.0 
 
 
 
 
 
50 
 
 
 
 
DYSPNEA 
 
 
DYSPNEA 
 FREQUENCY PERCENT 
Yes 4 8.0 
 
No 46 92.0 
 
   
 
 
 
HYPERTENSION 
 
HYPERTENSION 
 FREQUENCY PERCENT 
Yes 
7 14.0 
No 
43 86.0 
 
 
 
 
 
14%
86%
HYPERTENSION
Yes No
51 
 
 
 
 
DIABETES 
 
DIABETES 
 FREQUENCY PERCENT 
Yes 9 18.0 
 
No 41 82.0 
 
 
 
 
 
 
 
 
DYSLIPIDEMIA 
 
DYSLIPIDEMIA FREQUENCY PERCENT 
Yes 6 12.0 
 
No 44 88.0 
 
 
18%
82%
DIABETES
Yes No
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CORONARY ARTERY DISEASE 
 
Coronary artery 
disease 
 
Frequency Per cent 
Yes 5 10.0 
 
No 45 90.0 
 
  
HYPOTHYROIDISM 
 
HYPOTHYROIDISM 
 FREQUENCY PERCENT 
Yes 3 6.0 
 
No 47 94.0 
 
  
 
SLE 
 
SLE 
 FREQUENCY PERCENT 
Yes 2 4.0 
 
No 48 96.0 
 
  
PALLOR 
 
PALLOR 
 FREQUENCY PERCENT 
Yes 7 14.0 
 
No 43 86.0 
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SKIN LESION 
 
SKIN LESION 
 FREQUENCY PERCENT 
Yes 3 6.0 
 
No 47 94.0 
 
  
 
URINE PROTEIN 
 
URINE PROTEIN FREQUENCY PERCENT 
1+ 16 32.0 
 
2+ 14 28.0 
 
3+ 18 36.0 
 
4+ 2 4.0 
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URINE SUGAR 
 
URINE SUGAR 
 FREQUENCY PERCENT 
Nil 41 82.0 
 
2+ 5 10.0 
 
3+ 4 8.0 
 
 
 
HIV/HBsAg/AntiHCV 
 
HIV/HBsAg/Anti
HCV Frequency Per cent 
Negative 50 100.0 
 
 
ANA 
 
ANA 
 FREQUENCY PERCENT 
Positive 3 6.0 
 
Negative 47 94.0 
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CLINICAL DIAGNOSIS 
 
 
 
CLINICAL 
DIAGNOSIS 
 
FREQUENCY PERCENT 
Nephrotic Syndrome 28 56.0 
Nephritic Syndrome 6 12.0 
IGA Nephropathy 4 8.0 
DM Nephropathy 5 10.0 
Lupus Nephritis 2 4.0 
AKI 3 6.0 
RPGN 2 4.0 
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BIOPSY REPORT 
 
 
BIOPSY REPORT 
 FREQUENCY PERCENT 
Minimal Change Disease 7 14.0 
Membranous Nephropathy 10 20.0 
IGA Nephropathy 4 8.0 
FSGS 6 12.0 
PIGN 5 10.0 
MPGN 11 22.0 
Lupus Nephritis 2 4.0 
Others 5 10.0 
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DESCRIPTIVE STATISTICS 
 
 
VARIABLE MIN MAX MEAN STD. DEVIATION 
Age in years 14 69 35.14 13.337 
SBP 100 180 137.20 20.508 
DBP 60 110 85.40 12.651 
Hb 6.4 14.4 10.882 1.9355 
B.Urea 48 106 65.98 12.091 
S.Creatinine 1.1 14.1 2.684 1.8679 
Sr.Cholesterol 146 341 188.36 41.364 
TGL 96 172 114.84 14.933 
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Clinical Diagnosis VS Biopsy Report 
 
 
Clinical Diagnosis 
 
Biopsy Report 
Minimal 
Change 
Disease 
Memb
ranous  
IGA 
Nephr
opathy 
FSG
S 
PI
G
N 
MP
GN 
Lup
us  
Oth
ers 
Nephrotic 
Syndrome 5 9 2 5 2 5 0 0 
 
Nephritic Syndrome 1 0 0 0 3 1 1 0 
 
IGA Nephropathy 0 0 1 1 0 2 0 0 
 
DM Nephropathy 1 1 0 0 0 1 0 2 
 
Lupus Nephritis 0 0 0 0 0 0 1 1 
 
AKI 0 0 0 0 0 1 0 2 
 
RPGN 0 0 1 0 0 1 0 0 
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CLINICAL DIAGNOSIS VS BIOPSY REPORT 
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Biopsy Report VS Edema 
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Biopsy Report VS Oliguria 
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Biopsy Report VS Haematuria 
 
Patients with IGA nephropathy, FSGS, PIGN, MPGN and all patients 
with lupus nephritis had hematuria.  
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Biopsy Report VS Hypertension 
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Biopsy Report VS Diabetes 
Patients with diabetes mostly had membranous nephropathy and also 
MCD, MPGN. 
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Biopsy Report VS Dyslipidemia 
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Biopsy Report VSCAD 
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Biopsy Report VS Hypothyroidism 
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Biopsy Report VS SLE 
 
All patients with SLE had LUPUS NEPHRITIS in their renal biopsy. 
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Biopsy Report VS Skin Lesion 
 
 
Patients with skin lesion had either PIGN or SLE. 
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Biopsy Report VS Urine Protein 
 
  
 
 
 
 
 
 
 
Biopsy Report VS Urine Sugar 
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Biopsy Report VS S.Creatinine 
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Biopsy Report VSAge in years 
 
BIOPSY  AGE IN YEARS 
< 20 21-30 31-40 41-50 51-60 >60 
Minimal 
Change 
Disease 
3 0 3 0 1 0 
Membranous 
Nephropathy 2 1 0 3 3 1 
IGA 
Nephropathy 0 2 2 0 0 0 
FSGS 2 1 1 2 0 0 
PIGN 0 2 2 0 1 0 
MPGN 0 6 3 2 0 0 
Lupus 
Nephritis 1 0 1 0 0 0 
Others 0 0 2 2 1 0 
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Biopsy Report VS Sex 
 
  
 
BIOPSY REPORT 
SEX 
MALE FEMALE 
Minimal Change Disease 6 1 
Membranous Nephropathy 4 6 
IGA Nephropathy 1 3 
FSGS 4 2 
PIGN 3 2 
MPGN 7 4 
Lupus Nephritis 0 2 
Others 4 1 
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                                              DISCUSSION 
 
  Glomerular diseases are an important cause of end-stage kidney disease. 
The histologic spectrum of these is different in adults as compared with children 
as well as in tropical as compared with temperate countries. In the present 
study, primary glomerular diseases accounted for 89% cases of nephrotic 
syndrome, while LN was the most common secondary cause. Overall, 
membranous nephropathy was the most common cause of nephrotic syndrome. 
   
  An analysis of the spectrum of primary glomerular diseases as a cause of 
nephrotic syndrome during the last five decades has revealed a 5-fold increase 
in the frequency of FSGS. Along with that, there was a 3-fold increase in the 
frequency of MGN making it the second most cause of nephrotic syndrome 
while DPGN decreased to one-tenth of its earlier prevalence. There was no 
significant change in MCD or MPGN[48,49,50]. This trend is similar to the 
emerging global trend, which indicates an increase in the incidence of FSGS 
making it the number one cause of nephrotic syndrome world-wide. There can 
be a variety of reasons for this changing spectrum. This may be related to 
improvement in the overall quality-of-life, decreased rate of infections, better 
socio-economic status, increased incidence of obesity and changing pattern of 
indications for renal biopsy.  
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  A more widespread use of IF and electron microscopy in the analysis of 
renal biopsy can explain increased diagnosis of MGN and FSGS, which are 
otherwise likely to be misdiagnosed as MCD. 
   
  While the earlier studies found MCD to be the most common cause, more 
recent ones show results similar to our study. The study done from Vellore in 
1970's noted that MCD accounted for about 35% of all cases of nephrotic 
syndrome. Similarly, studies from Delhi and Rohtak, also found MCD to be 
responsible for more than one-third of nephrotic syndrome.[51,52] The study done 
at Vellore in 1990's found that the incidence of FSGS had increased from 15% 
to 19% and it became the most common underlying etiology for primary 
nephrotic syndrome.  
   
  In a recent study published from Kolkata, Golay et al.,found that FSGS 
was underlying disease in 27.4% of their patients making it the most common 
one while MGN was third most common accounting for about 25%. This figure 
is not similar to our present data, where FSGS and MGN were responsible for 
12% and 20% of cases respectively. However, they found MCD in 27.1% of 
cases, making it the second most common cause of nephrotic syndrome while 
MPGN was seen in only 18%. This is similar to our data where MPGN was 
seen in about 16% of cases while MCD was seen in around 15% of cases. The 
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exact reason for this difference is not clear. A possible explanation may be that 
only 5.6% of patients in their study were subjected to EM examination in 
contrast to about one-fourth in our study. 
   
  In a study published by Siegel et al., it was observed that EM is essential 
for correct diagnosis in 11% of cases and for confirmation of diagnosis in an 
additional 36%.[53] The incidence of IgAN was also less at 8% in our study as 
compared to 4-14% in other studies from India probably since the majority of 
those with IgAN do not have a nephrotic syndrome. 
       The data from the West are also conflicting. Studies done in USA have 
clearly demonstrated increasing incidence of FSGS particularly in African-
Americans making it the most common cause of nephrotic syndrome in their 
adult population. Not only this, the proportion of FSGS as cause of end-stage 
renal disease in USA has increased almost ten times in the last two 
decades.[54] Similarly, studies done from some other parts of the world have 
shown FSGS to be the most common cause of adult nephrotic syndrome.[55,56]  
 
  There is emerging evidence that its incidence in children is also 
increasing and a study done in Indian pediatric patients has demonstrated FSGS 
to be the most common cause in adolescents as compared with MCD in younger 
patients.[57] However, the data from some European countries including registry 
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data do not agree with this trend. Studies done from Italy and Spain have shown 
MGN to be the most common cause of adult nephrotic syndrome[58,59] while 
those from Denmark, the Czech republic and Romania have shown MCD, IgAN 
and MPGN respectively to be the most common lesions.[60,61,62] 
   
  While studies from Pakistan and Nepal have shown that IgAN is an 
infrequent cause of nephrotic syndrome with figures of around 2% the ones 
from China and Korea have found it to be very common. Changet al., observed 
that IgAN was responsible for 28.3% of nephrotic syndrome making it the most 
common cause in Korea. Zhou et al., found IgAN to be the second most 
common cause of nephrotic syndrome after MGN, accounting for 20% of cases 
in China. However, Kazi et al., from Pakistan have found FSGS to be the most 
common cause accounting for almost 40% of their cases, followed by MGN 
(26.6%) and MCD (14.8%).  
 
In 2006, Nair and walker after studying the 5 years results of renal 
biopsy, they reported that IgA nephropathy is the commonest primary 
glomerular disorder in United states and also in mid-western region. But focal 
segmental glomerulosclerosis is the commonest one in African Americans. 
Same results are reported by swaminathan et al in Minnesota, which explained 
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the order of prevalence as following; IgA nephropathy, focal segmental 
glomerulosclerosis and membranous nephropathy.  
 
A cross sectional study conducted by polito et al in Brazil reported the 
focal segmental glomerulosclerosis as most common one following which 
membranous nephropathy and IgA nephropathy respectively. He also 
mentioned that most common secondary glomerulopathy is lupus nephritis and 
next common is post infectious glomerulopathy. 
 
 In Europe the most common primary glomerulopathy is IgA nephropathy 
and the most common secondary glomerulopathy is lupus nephritis. The Asian 
picture also denotes the same. But in Middle East the commonest form is focal 
segmental glomerulopathy where the IgA nephropathy is only 6.5%. But most 
common secondary form is lupus nephritis as like as Europe. The Australian 
data also explains that IgA is the commonest one in their country. 
 
Out of 50 patients we had 8 patients under the age of 20, 12 patients 
between the age group of 21-30, 14 patients between the age group of 31-40, 9 
patients between the age group of 41-50, 6 patients above the age of 51. Out of 
50 patients 16 were smoker and 14 were alcoholic. 22 patients presented with 
edema, 14 patients presented with oliguria, 10 patients presented with hematuria 
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and 4 presented with dyspnoea.7 patients were known hypertensive , 9 were 
diabetic, 6 were dyslipidemic, 5 patients had ischemic heart disease, 3 had 
hypothyroidism and 2 were suspected as SLE. On examination pallor found in 7 
patients, skin lesion found in 3 patients.  
 
On laboratory investigation urine protein found 1+ in 16 patients, 2+ in 
14 patients, 3+ in 18 patients and 4+ in 2 patients. Urine sugar was found 
positive in 9 patients and negative in 41 patients. HBsAg, Anti-HCV and HIV 
were negative in all patients. ANA was found positive in 3 patients. The most 
common clinical diagnosis encountered in our study is nephrotic syndrome, 
next one is nephritic syndrome. IgA nephropathy was the clinical diagnosis in 4 
patients, Diabetic nephropathy in 5 patients, Lupus nephritis in 2 patients, acute 
kidney injury in 3 patients and RPGN in 2 patients.  
 
We had significant abnormalities in urine examination like granular casts, 
RBC casts and high proteins. Systolic blood pressure was found above 140 in 
28 patients and diastolic blood pressure was found above 90 in 27 patients. 
Haemoglobin was found less than 10 gm% in 15 patients and more than 10 in 
other patients. Lowest creatinine value found was 1.1mg% and highest was 
14.1mg%.  
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After renal biopsy, the most common types of histopathological diagnosis 
we had obtained are minimal change nephropathy and membranous 
nephropathy. IgA nephropathy was found in 4 patients, Focal segmental 
glomerulosclerosis was found in 6 patients, Post infectious glomerulonephritis 
was found in 5 patients, Membranoproliferative glomerulonephritis was found 
in 7 patients, Lupus nephritis was found in 2 patients and other categories were 
found in 5 patients which included thrombotic microangiopathy, crescentic 
nephritis and cast nephropathy.The P value of correlation of clinical and 
histopathological diagnosis is 0.006 and highly significant.  
 
Correlation of edema and histopathological diagnosis gave the P value of 
significant level. Correlation of hematuria and histopathological diagnosis was 
also found significant as the P value is 0.027. Correlating other symptoms like 
oliguria was found low significant. We also correlated the co-morbidities like 
hypertension, diabetes, dyslipidemia, coronary artery disease, hypothyroidism 
and systemic lupus erythematous with the biopsy result. Correlation of skin 
lesion with histopathological diagnosis is found to be highly significant.  
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In age distributionit is found that membranoproliferative 
glomerulonephritis is appears to be common in third decade of the life, 
membranous nephropathy appears to be common in fourth and fifth decade,  
post infectious and IgA nephropathy are appears to common in middle age 
group, minimal change nephropathy commonly found in under twenties and 
fourth decade, lupus nephritis appeared mostly in under forties.  
 
In sex distribution it is found that 70-80% of minimal change disease is 
seen in male whereas almost all lupus nephritis is seen in female. Focal 
segmental glomerulosclerosis, post infectious glomerulonephritis and 
membranoproliferative glomerulonephritis are more common in males than 
females. But IgA nephropathy and membranous nephropathy are more common 
in females than males. Other uncommon results like cast nephropathy, 
thrombotic microangiopathy and crescentic glomerulonephritis are found 
common in males.  
 
We had an interesting patient, who presented with acute renal failure and 
hypercalcemia. We evaluated that patient, he had multiple lytic bone lesions and 
myeloma picture in marrow biopsy and finally we identified cast nephropathy 
which was the cause for his renal failure. 
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                     CONCLUSION 
Our study revealed that some patients, who clinically presented with 
nephritic syndrome, were later diagnosed as nephrotic Syndrome after 
histopathological report of renal biopsy. Likewise some patients, who clinically 
presented with nephrotic syndrome, were later diagnosed as nephritic syndrome 
after renal biopsy report. Some of the clinically suspected acute kidney injury 
was also later diagnosed as chronic glomerular diseases after HPE report. These 
results show that the diagnosis based on the clinical presentation differs from 
histopathological diagnosis in many circumstances. So it will be more useful if 
we get a histopathological diagnosis before concluding the diagnosis and before 
starting the treatment, whenever needed. 
       As I mentioned earlier IgA nephropathy is the commonest primary 
glomerulopathy in most part of the world according to various reports. But our 
study showed that membranous nephropathy as the commonest one and 
minimal change disease as second most common. Though the MPGN appears 
common one it is not true, because for the purpose statistical analysis we 
included the membranoproliferative, mesangioproliferative and diffuse 
proliferative under the category of MPGN. In the category of other we included 
the rare forms like diabetic nephropathy, cast nephropathy, acute tubular 
necrosis and thrombotic microangiopathy. 
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      A cross sectional study of Italian registry of renal biopsy revealed that most 
common indication for renal biopsy is clinically diagnosed nephritic syndrome 
and second most common indication is urinary abnormalities. Hanko et al in 
United Kingdom reported about the changing pattern of the primary glomerular 
diseases and also the increasing rate of biopsy from 2.02 to 7.08 per hundred 
thousand populations per year. These data emphasises the importance of the 
maintenance of the national level and state level renal biopsy registry, initiation 
of national and state level screening programme for renal diseases and early 
identification of urinary abnormalities and prompt referral to nephrologist for 
renal biopsy. 
LIMITATIONS OF THE STUDY 
As this study is done in small group of patients in a single centre, a 
multicentre large study is needed for more clarification and better results. As 
extreme age group and post-transplant patients are excluded from this study, 
these results are not applicable for these categories. As I have mentioned earlier 
various studies in various part of the world reported the prevalence of the 
primary and secondary glomerular diseases in their institutes or states. So it is 
very difficult to delineate thechanging pattern of the renal diseases. Because of 
increasing biopsy rate, changing trend of the renal diseases and ethnical racial 
variability, the prevalence of various diagnosis in renal biopsy results are highly 
evolving over the time. 
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PROFORMA 
           NAME OF THE PATIENT:                                       OCCUPATION 
                                  AGE:                                        SMOKER/NON-
SMOKER 
                                   SEX:                                   ALCOHOLIC/NON-
ALCOHOLIC 
                               IP NO: 
   DATE OF ADMISSION: 
               DATE OF DISCHARGE: 
 
COMPLAINTS 
EDEMA 
              OLIGURIA 
              HEMATURIA 
              DYSPNOEA 
 
PAST H/O 
        PRIOR RENAL DISEASE 
        HT-DURATION/COMPLICATION 
 
        DM-DURATION/COMPLICATION 
        DYSLIPIDEMIA 
        CAD 
        HYPOTHYROIDISM 
        SLE 
        AMYLOIDOSIS 
DRUGS 
        NSAIDS 
        AMINOGLYCOSIDES 
        STEROIDS 
OHA 
         INSULIN 
         AHT 
HIV STATUS 
VIRAL MARKERS STATUS 
         HBV 
         HCV 
ANA 
ANTI DsDNA 
COMPLIMENTS 
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EXAMINATION FINDINGS  
                 PALLOR 
                 SKIN LESIONS 
                 ANASARCA 
     BP 
INVESTIGATIONS 
        URINE-PROTIEN 
                     SUGAR 
                     DEPOSITS 
        CBC 
 
        BLOOD SUGAR 
        UREA 
        CREATININE 
        SERUM ELECTROLYTES 
         LIPIDS 
VIRAL MARKERS 
        OTHERS 
     USG-KUB 
 
     ECG 
 
     ECHO 
 
 
CLINICAL DIAGNOSIS 
 
 
THERAPY 
 
 
DIALYSIS 
 
 
RECOVERY                                                     DEATH 
 
 
BIOPSY REPORT 
 
FINAL DIAGNOSIS 
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